Novartis reports Q2 earnings before the bell with investors parsing drug pipeline strength against relentless pricing headwinds across developed markets.
Novartis :
NVS
NVS
Stock Data
$154.21
$0.23 (0.15%)
Asset Type
Common Stock
Exchange
NYSE
Currency
USD
Country
USA
Sector
HEALTHCARE
Industry
DRUG MANUFACTURERS - GENERAL
Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.
Latest Activity
Reports Tue Jul 21Before openConfirmed
All Novartis Articles
136 Articles